Ruth O’Regan, Ph.D., works as an Associate Professor of hematology and medical oncology at the Winship Cancer Institute (WCI) of Emory University and as the Chief of hematology and medical oncology, Georgia Cancer Center for Excellence at Grady Memorial Hospital. She holds the Louisa and Rand Glenn Family Chair in Breast Cancer Research and serves as the Director of the Translational Breast Cancer Research program at WCI. Additionally, she directs the Hematology and Oncology Fellowship program and serves as the Vice Chair for Educational Affairs, Department of Hematology and Medical Oncology. She obtained her M.D. degree from University College, Dublin. She conducted a residency in internal medicine and a Fellowship in oncology at the Mater Hospital, Dublin. She completed her USA residency and fellowship at Northwestern University, and she joined the Faculty there in 1999. She won the Compassionate Care Award from the Women’s Board of Northwestern Hospital and the NSABP Young Clinical Investigator Award. Since joining the Faculty at the Emory Winship Cancer Institute, she has continued her research in SERM-resistance. Additionally, her laboratory focuses on the evaluation of novel targeted approaches for triple negative breast cancer, which has led to the development of novel trials for patients with this subtype of breast cancer. As a Georgia Cancer Coalition Distinguished Cancer Scholar, she serves as a Principal Investigator of the first two trials to be run through Georgia Cancer Coalition’s innovative Georgia Center for Oncology Research and Education (CORE). She is widely published in peer-reviewed scientific journals, including Lancet Oncology, the Journal of the National Cancer Institute, and the Journal of the American Medical Association.
Biography Updated on 3 March 2011